Afuco™ Anti-Human HLA-B27 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-HLA-B27 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies directed against hla-b27 homodimers are useful in the diagnosis and treatment of HLA-B27 mediated conditions, particularly those associated with B272, the spondylarthritides, a group of related diseases including ankylosing spondylitis (AS) and reactive arthritis (ReA or Reiter's syndrome).
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-344CL |
| Pricing | Inquiry |
| Host | Human |
| Target | HLA-B27 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C for long-term storage. Store at 4°C for up to one month. Avoid freeze/thaw cycles. |